Organogenesis Holding (NASDAQ: ORGO) reported Q3 EPS of $0.00, $0.10 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $116.9 million versus the consensus estimate of $128.92 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.